A
Alberto José da Silva Duarte
Researcher at University of São Paulo
Publications - 337
Citations - 7265
Alberto José da Silva Duarte is an academic researcher from University of São Paulo. The author has contributed to research in topics: Immune system & Medicine. The author has an hindex of 41, co-authored 304 publications receiving 6339 citations. Previous affiliations of Alberto José da Silva Duarte include Federal University of São Paulo.
Papers
More filters
Journal ArticleDOI
IRF8 mutations and human dendritic-cell immunodeficiency.
Sophie Hambleton,Sandra Salem,Jacinta Bustamante,Venetia Bigley,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Joana Azevedo,Anny Fortin,Muzlifah Haniffa,Muzlifah Haniffa,Lourdes Ceron-Gutierrez,Chris M. Bacon,Chris M. Bacon,Geetha Menon,Céline Trouillet,David McDonald,Peter Carey,Florent Ginhoux,Laia Alsina,Laia Alsina,Timothy J. Zumwalt,Xiao-Fei Kong,Dinakantha S. Kumararatne,Karina Butler,Marjorie Hubeau,Jacqueline Feinberg,Saleh Al-Muhsen,Andrew J. Cant,Laurent Abel,Laurent Abel,Damien Chaussabel,Rainer Doffinger,Eduardo Talesnik,Anete Sevciovic Grumach,Alberto José da Silva Duarte,Katia Abarca,Dewton Moraes-Vasconcelos,David L. Burk,Albert M. Berghuis,Frederic Geissmann,Matthew Collin,Jean-Laurent Casanova,Philippe Gros +42 more
TL;DR: These findings define a class of human primary immunodeficiencies that affect the differentiation of mononuclear phagocytes and show that human IRF8 is critical for the development of monocytes and dendritic cells and for antimycobacterial immunity.
Journal ArticleDOI
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
Ludovic de Beaucoudrey,Arina Samarina,Arina Samarina,Arina Samarina,Jacinta Bustamante,Jacinta Bustamante,Aurélie Cobat,Aurélie Cobat,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Jacqueline Feinberg,Saleh Al-Muhsen,Lucile Janniere,Yoann Rose,Maylis de Suremain,Xiao-Fei Kong,Orchidée Filipe-Santos,Ariane Chapgier,Capucine Picard,Alain Fischer,Figen Dogu,Aydan Ikinciogullari,Gonul Tanir,Sami Al-Hajjar,Suliman Al-Jumaah,Husn H. Frayha,Zobaida Alsum,Sulaiman Al-Ajaji,Abdullah A. Alangari,Abdulaziz Al-Ghonaium,Parisa Adimi,Davood Mansouri,Imen Ben-Mustapha,Judith Yancoski,Ben-Zion Garty,Carlos Rodríguez-Gallego,Isabel Caragol,Necil Kutukculer,Dinakantha S. Kumararatne,Smita Y. Patel,Rainer Doffinger,Andrew Exley,Olle Jeppsson,Janine Reichenbach,David Nadal,Yaryna Boyko,Barbara Pietrucha,Suzanne T. Anderson,Michael Levin,Liliane Schandené,Kinda Schepers,André Efira,Françoise Mascart,Masao Matsuoka,Tatsunori Sakai,Claire-Anne Siegrist,Klara Frecerova,Renate Blüetters-Sawatzki,Jutta Bernhöft,Joachim Freihorst,Ulrich Baumann,Darko Richter,Filomeen Haerynck,Frans De Baets,Vas Novelli,David A. Lammas,Christiane Vermylen,David Tuerlinckx,Chris Nieuwhof,Małgorzata Pac,Walther H. Haas,Ingrid Müller-Fleckenstein,Bernhard Fleckenstein,Jacob Levy,Revathi Raj,Aileen C. Cohen,David B. Lewis,Steven M. Holland,Kuender D Yang,Xiaochuan Wang,Xiaohong Wang,Li-Ping Jiang,Xi-qiang Yang,Chaomin Zhu,Yuanyuan Xie,Pamela Pui Wah Lee,Koon Wing Chan,Tong-Xin Chen,Gabriela Castro,Ivelisse Natera,Ana Codoceo,Alejandra King,Liliana Bezrodnik,Daniela Di Giovani,María Isabel Gaillard,Dewton Moraes-Vasconcelos,Anete Sevciovic Grumach,Alberto José da Silva Duarte,Ruth Aldana,Francisco J. Espinosa-Rosales,Mohammed Bejaoui,Ahmed Aziz Bousfiha,Jamila El Baghdadi,Namik Ozbek,Guzide Aksu,Melike Keser,Ayper Somer,Nevin Hatipoğlu,Cigdem Aydogmus,Suna Asilsoy,Yildiz Camcioglu,Saniye Gülle,Tuba Turul Ozgur,Meteran Ozen,Matías Oleastro,Andrea Bernasconi,Setareh Mamishi,Nima Parvaneh,Sergio D. Rosenzweig,Ridha Barbouche,Sigifredo Pedraza,Yu-Lung Lau,Mohammad S. Ehlayel,Claire Fieschi,Laurent Abel,Ozden Sanal,Jean-Laurent Casanova +127 more
TL;DR: An international survey of 141 patients from 102 kindreds in 30 countries found that IL-12R&bgr;1 deficiency has higher clinical penetrance, broader susceptibility to infections, and less favorable outcome than previously thought.
Journal ArticleDOI
Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency Medical and Immunological Implications
Claire Fieschi,Stéphanie Dupuis,Emilie Catherinot,Jacqueline Feinberg,Jacinta Bustamante,Adrien Breiman,Frédéric Altare,Richard Baretto,Françoise Le Deist,Samer Kayal,Hartmut Koch,Darko Richter,Martin Brezina,Guzide Aksu,Phil Wood,Suliman Al-Jumaah,Miquel Raspall,Alberto José da Silva Duarte,David Tuerlinckx,Jean Louis Virelizier,Alain Fischer,Andrea M. Enright,Jutta Bernhöft,Aileen M. Cleary,Christiane Vermylen,Carlos Rodríguez-Gallego,Graham Davies,Renate Blütters-Sawatzki,Claire-Anne Siegrist,Mohammad S. Ehlayel,Vas Novelli,Walther H. Haas,Walther H. Haas,Jacob Levy,Joachim Freihorst,Sami Al-Hajjar,David Nadal,Dewton de Moraes Vasconcelos,Olle Jeppsson,Necil Kutukculer,Klara Frecerova,Isabel Caragol,David A. Lammas,Dinakantha S. Kumararatne,Laurent Abel,Jean-Laurent Casanova +45 more
TL;DR: A diagnosis of IL-12Rβ1 deficiency should be considered in children with opportunistic mycobacteriosis or salmonellosis; healthy siblings of probands and selected cases of tuberculosis should also be investigated.
Journal ArticleDOI
Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis.
Gil Benard,Carla C. Romano,Camila R. Cacere,Michelangelo Juvenale,Maria José Soares Mendes-Giannini,Alberto José da Silva Duarte +5 more
TL;DR: The results suggest that the imbalance in cytokine production of patients with PCM plays a role in the gp43-hyporesponsiveness and the marked (non-protective) antibody production of these patients.
Journal ArticleDOI
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Ana Cristina Medeiros-Ribeiro,Nadia E. Aikawa,Carla G. S. Saad,Emily Figueiredo Neves Yuki,Tatiana do Nascimento Pedrosa,Solange R. G. Fusco,Priscila T Rojo,Rosa Maria Rodrigues Pereira,Samuel Katsuyuki Shinjo,Danieli Andrade,Percival D. Sampaio-Barros,Carolina Torres Ribeiro,Giordano B. H. Deveza,Victor Adriano de Oliveira Martins,Clovis A. Silva,Marta Heloísa Lopes,Alberto José da Silva Duarte,Leila Antonangelo,Ester Cerdeira Sabino,Esper G. Kallas,Sandra Gofinet Pasoto,Eloisa Bonfa +21 more
TL;DR: CoronaVac, an inactivated SARS-CoV-2 vaccine, has been approved for emergency use in several countries as mentioned in this paper, but its immunogenicity in immunocompromised individuals has not been well established.